EcoDrugPlus

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSOKIG00005050217
Gene Symbol: PTGS1
3 Cross references
206 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSOKIG00005035490
Gene Symbol: PTGS2
3 Cross references
202 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSOKIG00005005059
Gene Symbol: PSMA1
3 Cross references
199 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSOKIG00005014197
Gene Symbol: PSMA1
3 Cross references
204 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSOKIG00005011832
Gene Symbol: PSMA2
3 Cross references
201 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSOKIG00005050365
Gene Symbol: PSMA3
1 Cross references
232 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSOKIG00005008061
Gene Symbol: PSMA3
3 Cross references
233 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSOKIG00005048148
Gene Symbol: PSMA4
3 Cross references
212 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSOKIG00005015046
Gene Symbol: PSMA5
3 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSOKIG00005032399
Gene Symbol: PSMA6
1 Cross references
264 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSOKIG00005018423
Gene Symbol: PSMA6
1 Cross references
265 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSOKIG00005014161
Gene Symbol: PSMA7
1 Cross references
157 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).